Where is Allergan located?

Allergan is headquartered in Madison, United States.

How many employees does Allergan have?

As of Aug 31, 2026, the latest employee count at Allergan is 9755.

Is Allergan a funded company?

Allergan is a funded company, having raised an undisclosed amount across 16 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round.

How much is Allergan worth?

The last known valuation of Allergan was $***** as of Mar 03, 2021.

When was the latest funding round of Allergan?

Allergan's latest funding was a $***** Post IPO round on Jun 07, 2018, with participation from 1 investor.

What is the annual revenue of Allergan?

Annual revenue of Allergan is more than $1B as on Dec 31, 2019

Where does Allergan rank among its competitors?

Allergan ranks 55th amongst 1833 active competitors, of which 94 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of Allergan?

Allergan's top competitors include AbbVie, Gilead and Amgen. Among them, AstraZeneca secured the most recent funding round in July, 2025.

Allergan - 2026 Company Profile, Team, Funding, Competitors & Financials

Q: Is Allergan an acquired company?

Allergan got acquired by Pharmaron on Mar 03, 2021.

Allergan is an acquired company based in Madison (United States), founded in 1948 by Gavin S Herbert. It operates as a Developer and manufacturer of portfolio of generic medicines. Allergan has raised an undisclosed amount in funding, with last known valuation of $*****. The company has 1833 active competitors, including 94 funded and 204 that have exited. Its top competitors include companies like AbbVie, Gilead and Amgen.

Company Details

Allergan is a developer and manufacturer of a portfolio of generic medicines. It is focused on various therapeutic categories, including dermatology and aesthetics, CNS, eye care, women’s health, urology, GI and cystic fibrosis, cardiovascular, and infectious disease. In 2013 the company recorded annual revenues of $5.8B, and a net profit of $1.09B

Website: allergan.com
Email ID: *****@allergan.com
Phone Number: +1 **********
Part Of

Key Metrics

Founded Year

1948

Location

Madison, United States

Stage

Acquired

Latest Funding Round

Post IPO, Jun 07, 2018, $*****

Last Known Valuation

$***** as on Mar 03, 2021

Investors

Carl Icahn & 12 more

Ranked

55^th among 1833 active competitors

Annual Revenue

$1B+ as on Dec 31, 2019

Employee Count

9,755 as on Aug 31, 2026

Investment & Acquisitions

Stemson Therapeutics & 31 more

Similar Companies

AbbVie & 1861 more

Exit Details

Acquired by Pharmaron (Mar 03, 2021)

View Allergan's full profile

Allergan is associated with 5 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ALLERGAN INC CIN: 850693 , United States, Active	Apr 13, 1977	$1B+ (As on Dec 31, 2014)	-	-
ALLERGAN PLC CIN: 1578845 , United States, Active	Apr 13, 1977	$1B+ (As on Dec 31, 2019)	-	-
Abbvie Inc. CIN: 5126809 , United States, Active	Apr 09, 2012	$1B+ (As on Dec 31, 2025)	14619 (As on Dec 31, 2022)	-
ABBVIE HEALTHCARE INDIA PRIVATE LIMITED CIN: U85190KA2008PTC048318 , India, Active	Nov 18, 2008	₹100 - ₹500 Cr (As on Mar 31, 2025)	-
ABBVIE THERAPEUTICS INDIA PRIVATE LIMITED CIN: U33201KA1994PTC023162 , India, Active	Jul 04, 1994	₹500 - ₹1,000 Cr (As on Mar 31, 2026)	-

Allergan got acquired by Pharmaron on Mar 03, 2021 at an acquisition amount of $*****.

Click here to take a look at Allergan's acquisition in detail

Allergan has raised funding over 16 rounds. Its latest funding round was a Post IPO round on Jun 07, 2018 for $*****. 1 investor participated in its latest round. Allergan has 12 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Allergan:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 07, 2018	4508994	Post IPO	3191912	1588125	7365108	8179352
Sep 26, 2011	1039232	Grant (prize money)	7564603	1467314	9710875	NIH SBIR/STTR
Sep 21, 2011	9192368	Grant (prize money)	3083299	9789049	1645334	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Allergan's funding rounds and investors

The founders of Allergan is Gavin S Herbert.

Here are the details of Allergan's key team members:

Gavin S Herbert: Founder of Allergan.
Contact Info: 1 email address

View details of Allergan's Founder profiles and Board Members

Allergan's employee count trend

Allergan has 9,755 employees as of Aug 26. Here is Allergan's employee count trend over the years:

Uncover Allergan's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Allergan include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of Allergan, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 9 others	83/100
2nd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Jindal ventures & 17 others	81/100
3rd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	79/100
4th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	76/100
5th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	75/100
6th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 16 others	74/100
7th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 8 others	72/100
8th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	71/100
9th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 11 others	70/100
10th	Genentech 1976, San Francisco (United States), Acquired	R&D company focused on manufacturing drugs for multiple therapeutic areas	$72.5M	Ignite 500, The Column Group & 4 others	68/100
55th	Allergan 1948, Madison (United States), Acquired	Developer and manufacturer of portfolio of generic medicines	-	JANA Partners, Atlas Venture & 11 others	56/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Allergan's competitors? Click here to see the top ones

Allergan has made 3 investments in companies including Stemson Therapeutics and Correvio. Allergan has also acquired 29 companies including Envy Medical and Bonti.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jun 2019	Investments	Stemson Therapeutics	2019	San Diego (United States)
Mar 26, 2019	Acquisition	Envy Medical	1999	Long Beach (United States)
Sep 14, 2018	Acquisition	Bonti	2015	Newport Beach (United States)